Kelly Anderson is Director of Hillstream BioPharma Inc.. Currently has a direct ownership of 6,300 shares of HILS, which is worth approximately $18,144. The most recent transaction as insider was on Jun 23, 2025, when has been sold 6,300 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.3K
n/a 3M change
n/a 12M change
Total Value Held $18,144

Kelly Anderson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 23 2025
BUY
Grant, award, or other acquisition
-
6,300 Added 50.0%
6,300 Common Stock

Also insider at

TOMZ
TOMI Environmental Solutions, Inc. Industrials
GHSI
Guardion Health Sciences, Inc. Healthcare
UAVS
AgEagle Aerial Systems Inc. Technology
KA

Kelly Anderson

Director
Newport Beach, CA

Track Institutional and Insider Activities on HILS

Follow Hillstream BioPharma Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HILS shares.

Notify only if

Insider Trading

Get notified when an Hillstream Bio Pharma Inc. insider buys or sells HILS shares.

Notify only if

News

Receive news related to Hillstream BioPharma Inc.

Track Activities on HILS